课题基金 / 基金详情

CU-Catalyzed C(aryl)-N and C(aryl)-O Bond-forming Reactions

CU-Catalyzed C(aryl)-N and C(aryl)-O Bond-forming Reactions
CU 催化的 C(芳基)-N 和 C(芳基)-O 成键反应
批准号:
7323071
负责人:
Ryan A Altman
金额:
$3.87万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-10 至 2008-05-31

项目摘要

项目成果

Ryan A Altman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Summary The broad aim of the following research proposal involves the improvement of Cu-catalyzed C-N and C- O bond-forming reactions. Copper mediated nucleophilic substitution of aryl halides are frequently used in the pharmaceutical industry, especially by medicinal chemists, to form aromatic amines and aryl ethers, for the synthesis of potential drug targets. First, intermediates in the catalytic cycle will be isolated, characterized and further studied to gain insight into the mechanism of the reaction. These intermediates will be used to study interesting selectivities that have been observed with Cu-based catalyst systems. Second, new anionic and neutral ligands will be designed and applied in Cu-catalyzed C-heteroatom cross-couplings with the goal of creating systems that display better catalyst activity and stability, and which can operate under mild conditions. Third, new Cu-catalyzed C-heteroatom bond-forming reactions will be developed, and known reactions will be refined for use in organic synthesis. These include the Cu-catalyzed reactions of aryl iodides and bromides with nucleophiles to provide protected and unprotected phenols, silyl enol ethers, diaryl amines and triaryl amines. Relevance Aromatic-nitrogen and aromatic oxygen compounds are commonly found in photographic materials and in pharmaceutical targets with potential therapeutic applications. These structural motifs are commonly synthesized by copper-catalyzed carbon-nitrogen and carbon-oxygen bond forming reaction. The proposed research seeks to improve known and develop new copper-catalyzed bond-forming reactions for use by medicinal chemists in the pharmaceutical industry, as well as synthetic organic chemists in general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of CNS-Penetrant Tryptophan 2,3-Dioxygenase Degrading Ligands
  • 批准号:
    10511398
  • 项目类别:
  • 资助金额:
    $23.59万
  • 财政年份:
    2022
  • 负责人:
    Ryan A Altman
  • 依托单位:
Targeting Tryptophan Dioxygenase Degradation for Suppression of Tumor Immune Evasion
  • 批准号:
    10436036
  • 项目类别:
  • 资助金额:
    $22.06万
  • 财政年份:
    2022
  • 负责人:
    Ryan A Altman
  • 依托单位:
Targeting Tryptophan Dioxygenase Degradation for Suppression of Tumor Immune Evasion
  • 批准号:
    10557210
  • 项目类别:
  • 资助金额:
    $16.96万
  • 财政年份:
    2022
  • 负责人:
    Ryan A Altman
  • 依托单位:
Fluorination and Fluoroalkylation Strategies for Synthetic and Medicinal Chemistry
  • 批准号:
    10670073
  • 项目类别:
  • 资助金额:
    $40.79万
  • 财政年份:
    2017
  • 负责人:
    Ryan A Altman
  • 依托单位:
海外基金